KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company Showcase
Jersey Desk/10238860

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous infusion solutions that improve quality of life for patients, today announced that the Company will participate in the Gilmartin Group Emerging Growth Company Showcase on September 21, 2023.

KORU Medical's management is scheduled to present at the Gilmartin Group Emerging Growth Company Showcase on September 21, 2023 at 2:00 pm ET. Interested parties can access the live and archived webcast on the News/Events page of the Investors section of KORU Medical's website at www.korumedical.com.

More on Jersey Desk

• Emory Healthcare Systemwide Allied Health Hiring Event at the High Museum of Art
• TurnMississippiBlue.org Pledges A New Way Forward
• Thrive Leadership Institute, Inc. Partners with the City of East Orange to Empower Local Businesses
• HandicapMD Expands Leading Telemedicine Services for Disabled Parking Permits in Florida
• Essex County's Anna D. Banks to Help Train New Facilitators in Global Transformation Effort

About KORU Medical Systems: KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60^® and FreedomEdge^® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.

Contacts

Investor Contact:
Greg Chodaczek
347-620-7010
investor@korumedical.com

---

Show All News | Report Violation